A cross-sectional study of secondary cardiac care in general practice: Impact of personal and practice characteristics

Family Practice

Volumn 23, Issue 3, 2006, Pages 295-302

  Byrne, Molly ^a   Murphy, Andrew W ^a   Walsh, Jane C ^a   Shryane, Eithne ^a   McGroarty, Mary ^b   Kelleher, Cecily C ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Angina; Arteriogram; Coronary heart disease; Lipid lowering; Secondary prevention; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; ANGIOCARDIOGRAPHY; AORTOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTICE; HEART INFARCTION; HUMAN; IRELAND; MALE; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; RURAL POPULATION; SEX DIFFERENCE; SOCIOECONOMICS;

AGE FACTORS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; AORTOGRAPHY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IRELAND; MALE; MYOCARDIAL INFARCTION; PROFESSIONAL PRACTICE; RURAL POPULATION; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 34548178102     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cml003     Document Type: Article

References (22)

1. McAlister F, Lawson F, Teo K, Armstrong P. Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 2001; 323: 957-962.
2. Bradley F, Cupples ME. Reducing the risk of recurrent coronary heart disease. BMJ 1999; 318: 1499-1500.
3. Faergeman O. A collective failure of medical practice? Eur Heart J 2001; 22: 526-528.
4. Starfield B. Primary Care: Balancing Health Needs, Services and Technology, 2nd edn. Oxford: Oxford University Press; 1998.
5. Campbell NC, Ritchie LD, Thain J, Deans HG, Rawles JM, Squair JL. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998; 80: 447-452.
6. Jolly K, Bradley F, Sharp S et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 1999; 318: 706-711.
7. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ 1998; 316: 1430-1434.
8. Moher M, Yudkin P, Wright L et al. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ 2001; 322: 1338.
9. Carroll K, Majeed A, Firth C, Gray J. Prevalence and management of coronary heart disease in primary care: population-based cross-sectional study using a disease register. J Public Health Med 2003; 25: 29-35.
10. deWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG. Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart 2003; 89: 417-421.
11. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 2001; 322: 832.
12. Majeed A, Moser K, Maxwell R. Age, sex and practice variations in the use of statins in general practice in England and Wales. J Public Health Med 2000; 22: 275-279.
13. Reid FD, Cook DG, Whincup PH. Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart 2002; 88: 15-19.
14. Wood D, DeBacker G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-1503.
15. Byrne M, Walsh J, Murphy A. Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour. J Psychosom Res 2005; 58: 403-415.
16. Godin G, Shephard R. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985; 10: 141-146.
17. Roe L, Strong C, Whiteside C, Neil A, Mant D. Dietary intervention in primary care: validity of the DINE method for diet assessment. Fam Pract 1994; 11: 375-381.
18. Qureshi AI, Suri FK, Guterman LR, Hopkins N. Ineffective secondary prevention in survivors of cardiovascular events in the US population. Arch intern Med 2001; 161: 1621-1628.
19. Vale MJ, Jelinek MV, Best JD et al. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med 2003; 163: 2775-2783.
20. Lawlor DA, Whincup P, Emberson JR, Rees K, Walker M, Ebrahim S. The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart Study. Fam Pract 2004; 21: 582-586.
21. Heartwatch Steering Committee. HeartWatch Annual Report; Dublin. 2004. http://www.icgp.ie/index.cfm/loc/6-4.htm (accessed 12 October 2005).
22. Euroaspire I, Group II, European Action on Secondary Prevention by Intervention to Reduce E. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001; 357: 995-1001.